Phase II Basket Trial: Zanidatamab Plus Tislelizumab in HER2-Positive GI Tumors (UNION-HER2-BASKET)

Clinical trial NCT07243938 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07243938
Sponsor: Tao Zhang
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Rectal Cancer (LARC)Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma Metastatic Colorectal Cancer (mCRC)Neoadjuvant Therapy

Start date: 2026-01-15
Primary completion: 2028-07-30
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.